Literature DB >> 22968546

Enhanced dissolution and stability of lansoprazole by cyclodextrin inclusion complexation: preparation, characterization, and molecular modeling.

Yi Lu1, Tao Guo, Jianping Qi, Jiwen Zhang, Wei Wu.   

Abstract

In this study, lansoprazole (LSP)/cyclodextrin (CD) inclusion complexes were prepared using a fluid bed coating technique, with β-cyclodextrin (β-CD) and 2-hydroxypropyl-β-cyclodextrin (HPCD) as the host molecules, respectively, to simultaneously improve the dissolution and stability of LSP. The dissolution rate and stability of LSP was dramatically enhanced by inclusion complexation regardless of CD type. LSP/HPCD inclusion complex was more stable under illumination than LSP/β-CD inclusion complex. Differential scanning calorimetry and powder X-ray diffractometry proved the absence of crystallinity in both LSP/CD inclusion complexes. Fourier transform infrared spectroscopy together with molecular modeling indicated that the benzimidazole of LSP was included in the cavity of both CDs, while LSP was more deeply included in HPCD than β-CD. The enhanced photostability was due to the inclusion of the sulfinyl moiety into the HPCD cavity. CD inclusion complexation could improve the dissolution and stability of LSP.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22968546      PMCID: PMC3513431          DOI: 10.1208/s12249-012-9842-z

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  22 in total

Review 1.  Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors.

Authors:  C A Stedman; M L Barclay
Journal:  Aliment Pharmacol Ther       Date:  2000-08       Impact factor: 8.171

2.  Efficacy of proton pump inhibitor drugs against Plasmodium falciparum in vitro and their probable pharmacophores.

Authors:  Michael A Riel; Dennis E Kyle; Apurba K Bhattacharjee; Wilbur K Milhous
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

3.  Cyclodextrin complexation: influence on the solubility, stability, and cytotoxicity of camptothecin, an antineoplastic agent.

Authors:  Jichao Kang; Vijay Kumar; Dong Yang; Priyanka Roy Chowdhury; Raymond J Hohl
Journal:  Eur J Pharm Sci       Date:  2002-03       Impact factor: 4.384

4.  Interaction of omeprazole with a methylated derivative of beta-cyclodextrin: phase solubility, NMR spectroscopy and molecular simulation.

Authors:  Ana Figueiras; J M G Sarraguça; Rui A Carvalho; A A C C Pais; Francisco J B Veiga
Journal:  Pharm Res       Date:  2006-12-20       Impact factor: 4.200

Review 5.  Review article: pharmacokinetic concerns in the selection of anti-ulcer therapy.

Authors:  E A Lew
Journal:  Aliment Pharmacol Ther       Date:  1999-10       Impact factor: 8.171

Review 6.  Cyclodextrins and their pharmaceutical applications.

Authors:  Thorsteinn Loftsson; Dominique Duchêne
Journal:  Int J Pharm       Date:  2006-11-09       Impact factor: 5.875

7.  Phase solubility behavior of hydrophilic polymer/cyclodextrin/lansoprazole ternary system studied at high polymer concentration and by response surface methodology.

Authors:  Yi Lu; Ning Tang; Jianping Qi; Wei Wu
Journal:  Pharm Dev Technol       Date:  2010-11-10       Impact factor: 3.133

8.  Influences of sodium carbonate on physicochemical properties of lansoprazole in designed multiple coating pellets.

Authors:  Wei He; Min Yang; Jun Hong Fan; Cai Xia Feng; Su Juan Zhang; Jin Xu Wang; Pei Pei Guan; Wei Wu
Journal:  AAPS PharmSciTech       Date:  2010-08-18       Impact factor: 3.246

9.  Molecular dynamics simulations of beta-cyclodextrin in aqueous solution.

Authors:  Luckhana Lawtrakul; Helmut Viernstein; Peter Wolschann
Journal:  Int J Pharm       Date:  2003-04-30       Impact factor: 5.875

10.  Piroxicam/2-hydroxypropyl-beta-cyclodextrin inclusion complex prepared by a new fluid-bed coating technique.

Authors:  Xingwang Zhang; Danni Wu; Jie Lai; Yi Lu; Zongning Yin; Wei Wu
Journal:  J Pharm Sci       Date:  2009-02       Impact factor: 3.534

View more
  7 in total

1.  Preparation and evaluation of enteric coated tablets of hot-melt extruded lansoprazole.

Authors:  Bader B Alsulays; Vijay Kulkarni; Sultan M Alshehri; Bjad K Almutairy; Eman A Ashour; Joseph T Morott; Abdullah S Alshetaili; Jun-Bom Park; Roshan V Tiwari; Michael A Repka
Journal:  Drug Dev Ind Pharm       Date:  2016-08-21       Impact factor: 3.225

2.  Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.

Authors:  Xingwang Zhang; Tianpeng Zhang; Yali Lan; Baojian Wu; Zhihai Shi
Journal:  AAPS PharmSciTech       Date:  2015-07-18       Impact factor: 3.246

3.  Novel patchouli alcohol ternary solid dispersion pellets prepared by poloxamers.

Authors:  Jin-Bin Liao; Yong-Zhuo Liang; Yun-Long Chen; Jian-Hui Xie; Wei-Hai Liu; Jian Nan Chen; Xiao-Ping Lai; Zi-Ren Su
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

4.  Improvement of Skin Penetration, Antipollutant Activity and Skin Hydration of 7,3',4'-Trihydroxyisoflavone Cyclodextrin Inclusion Complex.

Authors:  Pao Hsien Huang; Stephen Chu Sung Hu; Feng Lin Yen; Chih Hua Tseng
Journal:  Pharmaceutics       Date:  2019-08-08       Impact factor: 6.321

5.  Co-solvation effect on the binding mode of the α-mangostin/β-cyclodextrin inclusion complex.

Authors:  Thanyada Rungrotmongkol; Uracha Ruktanonchai; Chompoonut Rungnim; Sarunya Phunpee; Manaschai Kunaseth; Supawadee Namuangruk; Kanin Rungsardthong
Journal:  Beilstein J Org Chem       Date:  2015-11-25       Impact factor: 2.883

6.  Combined Curcumin and Lansoprazole-Loaded Bioactive Solid Self-Nanoemulsifying Drug Delivery Systems (Bio-SSNEDDS).

Authors:  Abdulrahman Alshadidi; Ahmad Abdul-Wahhab Shahba; Ibrahim Sales; Md Abdur Rashid; Mohsin Kazi
Journal:  Pharmaceutics       Date:  2021-12-21       Impact factor: 6.321

Review 7.  Photosensitive drugs: a review on their photoprotection by liposomes and cyclodextrins.

Authors:  Giuseppina Ioele; Michele De Luca; Antonio Garofalo; Gaetano Ragno
Journal:  Drug Deliv       Date:  2017-12       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.